Healthtech funding in Q1 2022
European Healthtech startup funding raised during Q1 2022.
In Q1 2022, 171 European Healthtech companies closed 171 funding rounds and raised €2.2B in equity funding (excluding debt and grants), up 56.5% versus Q1 2021. Debt rounds added €500M. France led by capital raised, and INKEF Capital was the most active investor. Data as of 20 Nov 2026.
Equity funding
€2.2B
+56.5% vs Q1 2021 · excl. debt & grants · +€500M debt
Funding rounds
171
+80.0% vs Q1 2021
Companies
171
Top country
France
Rank among sectors
#4
7.7% of sector funding
Debt financing
€500M
18.7% of total
Top-10 round share
48.8%
of disclosed capital
Rounds ≥ €100M
3
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, Q1 2022 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €1.0B | 65 |
| Feb | €790M | 60 |
| Mar | €916M | 46 |
Top countries
by € raisedHealthtech — top countries by capital, Q1 2022 — interactive chart.
Data table
| Healthtech — top countries by capital, Q1 2022 | |
|---|---|
| France | €808M |
| UK | €566M |
| Netherlands | €362M |
| Switzerland | €268M |
| Germany | €240M |
| Belgium | €108M |
| Italy | €93M |
| Spain | €69M |
Stage mix
by € raisedHealthtech — stage mix, Q1 2022 — interactive chart.
Data table
| Healthtech — stage mix, Q1 2022 | |
|---|---|
| Other | €717M |
| Series B | €645M |
| Series A | €567M |
| Debt | €500M |
| Series C | €80M |
| Series D+ | €80M |
| Seed | €60M |
| Grant | €17M |
| Pre-Seed | €9.1M |
| Crowdfunding | €1.3M |
Exits & M&A
19 Acquisition19 exits · €4.2B disclosed.
| Pharma Intelligence | Acquisition | Feb 2022 | €2.3B |
| Zogenix | Acquisition | Jan 2022 | €1.7B |
| Optima | Acquisition | Jan 2022 | €162M |
| Klara | Acquisition | Feb 2022 | €87M |
| GP Service | Acquisition | Feb 2022 | €17M |
Top deals
largest disclosed rounds in Q1 2022| Company | Stage | Date | Amount |
|---|---|---|---|
| Doctolib | Debt | Mar 2022 | €500M |
| Patient21 | Other | Jan 2022 | €126M |
| Leyden Labs | Series B | Jan 2022 | €124M |
| MindMaze | Other | Feb 2022 | €92M |
| Ori Biotech | Series B | Jan 2022 | €88M |
| Padoa | Other | Feb 2022 | €80M |
| Precirix | Series B | Mar 2022 | €80M |
| DistalMotion | Series D+ | Jan 2022 | €80M |
| Ambagon Therapeutics | Series A | Jan 2022 | €75M |
| Microbiotica | Series B | Mar 2022 | €61M |
| EyeBiotech | Series A | Feb 2022 | €57M |
| SpliceBio | Series A | Feb 2022 | €50M |
| InnovHeart | Series C | Jan 2022 | €49M |
| Engitix | Series A | Jan 2022 | €48M |
| Automata Technologies | Series B | Feb 2022 | €44M |
Top investors
most active in Q1 2022, by deal count- INKEF Capital6 deals
- Bpifrance5 deals
- Octopus Ventures5 deals
- High-Tech Gründerfonds (HTGF)4 deals
- Venture Kick4 deals
- Acequia Capital3 deals
- BaseLaunch3 deals
- Capital Cell3 deals
- CDTI3 deals
- ENISA3 deals